Despite these limitations, our observational data provide timely and important insights that may inform future research. They described their findings that GLP-1 RAs are associated with decreases in RA disease activity, cardiovascular risk factors, and pain in patients with RA and overweight or obesity as promising and said they could have substantial clinical implications for this patient population
Use cautiously in patients with hyperthyroidism, hypertension and cardiac arrhythmias Side Effects: Transient and minor side effects of: Anxiety Tachycardia Headache Fear and palpitations occur with systemic therapeutic doses Adverse effects such as cardiac arrhythmias and excessive rise in blood pressure may also occur with therapeutic doses or inadvertent overdosage Side effects are more likely to be observed in hyperthyroid individuals Pharmacokinetics: Route of administration depends on the indication for its use : i.v., s.c., i.m., intranasal, via an endotracheal tube, or direct injection into the left ventricle
Researchers comparing GHRH-family compounds often cross-reference approved or clinically advanced analogs to understand what a successful regulatory path looks like
"The EMI programme exemplifies how a collaboration between academia and industry supporting new clinical investigators provides clear mutual benefits
The ANOVA did not reveal evidence of a significant treatment interaction between the two groups of mice, F( 3, 24 ) = 0.067
